# Itamar Raz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/itamar-raz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,842 |
| Field | Diabetes Treatment and Management |
| h-index | 77 |
| i10-index | 299 |
| Last Known Institution | Hebrew University of Jerusalem |
| OpenAlex ID | https://openalex.org/A5073517018 |
| ORCID iD | 0000-0003-0209-4453 |
| Works | 543 |

## Researcher papers

Showing 12 of 14.

- [Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes](https://scholariq.org/papers/renoprotective-effect-of-the-angiotensin-receptor-antagonist-irbesartan-in/)
- [Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus](https://scholariq.org/papers/saxagliptin-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials](https://scholariq.org/papers/sglt2-inhibitors-for-primary-and-secondary-prevention-of-cardiovascular-and/)
- [Type 2 diabetes mellitus](https://scholariq.org/papers/type-2-diabetes-mellitus/)
- [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-executive/)
- [Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus](https://scholariq.org/papers/comparison-of-the-effects-of-glucagon-like-peptide-receptor-agonists-and-sodium/)
- [Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial](https://scholariq.org/papers/heart-failure-saxagliptin-and-diabetes-mellitus-observations-from-the-savor-timi/)
- [Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ](https://scholariq.org/papers/low-ratio-of-fat-to-carbohydrate-oxidation-as-predictor-of-weight-gain-study-of/)
- [Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus](https://scholariq.org/papers/efficacy-and-safety-of-the-dipeptidyl-peptidase-4-inhibitor-sitagliptin-as/)
- [Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus](https://scholariq.org/papers/effect-of-dapagliflozin-on-heart-failure-and-mortality-in-type-2-diabetes/)
- [Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus](https://scholariq.org/papers/effect-of-dapagliflozin-on-atrial-fibrillation-in-patients-with-type-2-diabetes/)
- [Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials](https://scholariq.org/papers/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-hyperkalemia-in-people/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Hebrew University of Jerusalem](https://scholariq.org/institutions/hebrew-university-of-jerusalem/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.